Researchers and practitioners in health behavior and health education (HBHE) can play a pivotal leadership role in the integration of genomic advances to improve the public’s health. The purpose of this article is to outline research and practice opportunities at the intersection of genomics and HBHE. We begin this article by briefly summarizing the existing evidence in the literature pertaining to the public’s use of genetic services, the effectiveness of genetic counseling, and the impact of genetic testing. Following this, we outline and expand on several areas that we believe are ripe for further exploration, understanding, and public health application:(a) public understanding of genetic information, (b) interventions for health behavior change, and (c) public health assurance and advocacy. This analysis has identified the need to consider potential application efforts in genomics and HBHE from an ecological perspective, with an emphasis on multiple levels of intervention and analysis.
Apse, K. A., Biesecker, B. B., Giardiello, F. M., Fuller, B. P., & Bernhardt, B. A. (2004). Perceptions of genetic discrimination among at-risk relatives of colorectal cancer patients. Genetics in Medicine, 6(6), 510-516.
2.
Armstrong, K., Weber, B., FitzGerald, G., Hershey, J. C., Pauly, M. V., Lemaire, J., et al. (2003). Life insurance and breast cancer risk assessment: Adverse selection, genetic testing decisions, and discrimination. American Journal of Medical Genetics, 120A, 359-364.
3.
Armstrong, K., Weber, B., Stopfer, J., Calzone, K., Putt, M., Coyne, J., et al. (2003). Early use of clinical BRCA1/2 testing: Associations with race and breast cancer risk. American Journal of Medical Genetics, 117A, 154-160.
4.
Audrain, J., Boyd, N. R., Roth, J., Main, D., Caparaso, N. E., & Lerman, C. (1997). Genetic susceptibility testing in smoking-cessation treatment: One-year outcomes of a randomized trial. Addictive Behaviors, 22(6), 741-751.
5.
Audrain, J., Schwartz, M. D., Lerman, C., Hughes, C., Peshkin, B. N., & Biesecker, B. (1997). Psychological distress in women seeking genetic counseling for breast-ovarian cancer risk: The contributions of personality and appraisal. Annals of Behavioral Medicine, 19(4), 370-377.
6.
Bates, B. R., Lynch, J. A., Bevan, J. L., & Condit, C. M. (2005). Warranted concerns, warranted outlooks: A focus group study of public understandings of genetic research. Social Science and Medicine, 60, 331-344.
7.
Bates, B. R., Templeton, A., Achter, P. J., Harris, T. M., & Condit, C. M. (2003). What does “a gene for heart disease” mean? A focus group study of public understandings of genetic risk factors. American Journal of Medical Genetics, 119A, 156-161.
8.
Bekker, H., Modell, M., Dennis, S. G., Silver, A., Mathew, C., Bobrow, M., et al. (1993). Uptake of cystic fibrosis carrier testing in primary care: Supply push or demand pull?BMJ, 306, 1584-1586.
9.
Biesecker, B. B. (2001). Goals of genetic counseling. Clinical Genetics, 60, 323-330.
10.
Biesecker, B. B., & Peters, K. F. (2001). Process studies in genetic counseling: Peering into the black box. American Journal of Medical Genetics, 106, 191-198.
11.
Bloch, M., Fahy, M., Fox, S., & Hayden, M. R. (1989). Predictive testing for Huntington disease: II. Demographic characteristics, life-style patterns, attitudes, and psychosocial assessments of the first fifty-one test candidates. American Journal of Medical Genetics, 32(2), 217-224.
12.
Bosompra, K., Flynn, B. S., Ashikaga, T., Rairikar, C. J., Worden, J. K., & Solomon, L. J. (2000). Likelihood of undergoing genetic testing for cancer risk: A population-based study. Preventive Medicine, 30, 155-166.
13.
Botkin, J. R., Smith, K. R., Croyle, R. T., Baty, B. J., Wylie, J. E., Dutson, D., et al. (2003). Genetic testing for BRCA1 mutation: Prophylactic surgery and screening behavior in women 2 years post testing. American Journal of Medical Genetics, 118A, 201-209.
14.
Braithwaite, D., Emery, J., Walter, F., Prevost, A. T., & Sutton, S. (2004). Psychological impact of genetic counseling for familial cancer: A systematic review and meta-analysis. Journal of the National Cancer Institute, 96(2), 122-133.
15.
Broadstock, M., Michie, S., & Marteau, T. (2000). Psychological consequences of predictive genetic testing: A systematic review. European Journal of Human Genetics, 8, 731-738.
16.
Bubela, T. M., & Caulfield, T. A. (2004). Do the print media “hype” genetic research? A comparison of newspaper stories and peer-reviewed research papers. Canadian Medical Association Journal, 170(9), 1399-1407.
17.
Burke, W., Pinsky, L. E., & Press, N. A. (2001). Categorizing genetic tests to identify their ethical, legal, and social implications. American Journal of Medical Genetics, 106, 233-240.
18.
Condit, C. M., Dubriwny, T., Lynch, J., & Parrott, R. (2004). Lay people’s understanding of and preferences against the word “mutation.”American Journal of Medical Genetics, 130A, 245-250.
19.
Condit, C. M., Parrott, R. L., Harris, T. M., Lynch, J., & Dubriwny, T. (2004). The role of “genetics” in popular understandings of race in the United States. Public Understanding of Science, 13, 249-272.
20.
Coyne, J. C., Benazon, N. R., Gaba, C. G., Calzone, K., & Weber, B. L. (2000). Distress and psychiatric morbidity among women from high-risk breast and ovarian cancer families. Journal of Consulting and Clinical Psychology, 68(5), 864-874.
21.
Coyne, J. C., Druus, L., Kaqee, A., Thompson, R., & Palmer, S. (2002). Benign mental health consequences of screening for mutations of BRCA1/2. American Journal of Medical Genetics, 107(4), 346-347.
22.
Craufurd, D., Dodge, A., Kerzin-Storrar, L., & Harris, R. (1989). Uptake of presymptomatic predictive testing for Huntington’s disease. Lancet, 2(8663), 603-605.
23.
Croyle, R. T., Smith, K. R., Botkin, J. R., Baty, B., & Nash, J. (1997). Psychological responses to BRCA1 mutation testing: Preliminary findings. Health Psychology, 16(1), 63-72.
24.
Cull, A., Anderson, E. D. C., Campbell, S., Mackay, J., Smyth, E., & Steel, M. (1999). The impact of genetic counselling about breast cancer risk on women’s risk perceptions and levels of distress. British Journal of Cancer, 79(3/4), 501-508.
25.
Evers-Kiebooms, G., & van den Berghe, H. (1979). Impact of genetic counseling: A review of published follow-up studies. Clinical Genetics, 15, 465-474.
26.
Finkler, K., Skrzynia, C., & Evans, J. P. (2003). The new genetics and its consequences for family, kinship, medicine and medical genetics. Social Science and Medicine, 57, 403-412.
27.
Fischhoff, B., Bostrom, A., & Quadrel, M. J. (1997). Risk perception and communication. In R. Detels, W. W. Holland, J. McEwen, & G. S. Omenn (Eds.), Oxford textbook of public health (3rd ed., Vol. 2, pp. 987-1002). New York: Oxford University Press.
28.
Giardiello, F. M., Brensinger, J. D., Peterson, G. M., Luce, M. C., Hylind, L. M., Bacon, J. A., et al. (1997). The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. New England Journal of Medicine, 336(12), 823-827.
29.
Gollust, S. E., Apse, K., Fuller, B. P., Miller, P. S., & Biesecker, B. B. (2005). Community involvement in developing policies for genetic testing: Assessing the interests and experiences of individuals affected by genetic conditions. American Journal of Public Health, 95(1), 35-41.
30.
Gollust, S. E., Hull, S. C., & Wilfond, B. S. (2002). Limitations in direct-to-consumer advertising for clinical genetic testing. Journal of the American Medical Association, 288(14), 1762-1767.
31.
Hadley, D. W., Jenkins, J. F., Dimond, E., de Carvalho, M., Kirsch, I., & Palmer, C. G. S. (2004). Colon cancer screening practices after genetic counseling and testing for hereditary nonpolyposis colorectal cancer. Journal of Clinical Oncology, 22(1), 30-44.
32.
Haga, S. B., Khoury, M. J., & Burke, W. (2003). Genomic profiling to promote a healthy lifestyle: Not ready for prime time. Nature Genetics, 34(4), 347-350.
33.
Hall, M. A., & Rich, S. S. (2000). Laws restricting health insurers’ use of genetic information: Impact on genetic discrimination. American Journal of Human Genetics, 66, 293-307.
34.
Hallowell, N., Foster, C., Ardern-Jones, A., Eeles, R., Murday, V., & Watson, M. (2002). Genetic testing for women previously diagnosed with breast/ovarian cancer: Examining the impact of BRCA1 and BRCA2 mutation searching. Genetic Testing, 6(2), 79-87.
35.
Hallowell, N., & Richards, M. P. M. (1997). Understanding life’s lottery: An evaluation of studies of genetic risk awareness. Journal of Health Psychology, 21(1), 31-43.
36.
Hartley, N. E., Scotcher, D., Harris, H., Williamson, P., Wallace, A., Craufurd, D., et al. (1997). The uptake and acceptability to patients of cystic fibrosis carrier testing offered in pregnancy by the GP. Journal of Medical Genetics, 34(6), 459-464.
37.
Harvey-Berino, J., Gold, E. C., West, D. S., Shuldiner, A. R., Walston, J., Starling, R. D., et al. (2001). Does genetic testing for obesity influence confidence in the ability to lose weight? A pilot investigation. Journal of the American Dietetic Association, 101(11), 1351-1353.
38.
Hopwood, P., Howell, A., Lalloo, F., & Evans, G. (2003). Do women understand the odds? Risk perceptions and recall of risk information in women with a family history of breast cancer. Community Genetics, 6, 214-223.
39.
Institute of Medicine. (2003). The future of the public’s health in the 21st century. Washington, DC: National Academies Press.
40.
Institute of Medicine. (2005). Implications of genomics for public health: Workshop summary. Washington, DC: National Academies Press.
41.
Jacobellis, J., Martin, L., Engel, J., VanEenwyk, J., Bradley, L. A., Kassim, S., et al. (2004). Genetic testing for breast and ovarian cancer susceptibility: Evaluating direct-to-consumer marketing—Atlanta, Denver, Raleigh-Durham, and Seattle, 2003. Morbidity and Mortality Weekly Report, 53(27), 603-606.
42.
Jacobsen, P. B., Lamonde, L. A., Honour, M., Kash, K., Hudson, P. B., & Pow-Sang, J. (2004). Relation of family history of prostate cancer to perceived vulnerability and screening behavior. Psycho-Oncology, 13, 80-85.
43.
Jacobsen, P. B., Valdimarsdottir, H. B., Brown, K. L., & Offit, K. (1997). Decision-making about genetic testing among women at familial risk for breast cancer. Psychosomatic Medicine, 59, 459-466.
44.
Johnson, J., Giles, R. T., Larsen, L., Ware, J., Adams, T., & Hunt, S. C. (2005). Utah’s family high risk program: Bridging the gap between genomics and public health. Preventing Chronic Disease [serial online], 2(2). Available from http://www.cdc.gov/pcd/issues/2005/apr/04_0132.htm
45.
Johnson, K. A., Rosenblum-Vos, L., Petersen, G. M., Brensinger, J. D., Giardiello, F. M., & Griffin, C. A. (2000). Response to genetic counseling and testing for the APC I1307K mutation. American Journal of Medical Genetics, 91, 207-211.
46.
Johnson, K. A., Trimbath, J. D., Petersen, G. M., Griffin, C. A., & Giardiello, F. M. (2002). Impact of genetic counseling and testing on colorectal cancer screening behavior. Genetic Testing, 6(4), 303-306.
47.
Khoury, M. J. (1997). Relationship between medical genetics and public health: Changing the paradigm of disease prevention and the definition of a genetic disease. American Journal of Medical Genetics, 71, 289-291.
48.
Kua, E., Reder, M., & Grossel, M. J. (2004). Science in the news: A study of reporting genomcs. Public Understanding of Science, 13, 309-322.
49.
Lanie, A. D., Jayaratne, T. E., Sheldon, J. P., Kardia, S. L. R., Anderson, E. S., Feldbaum, M., et al. (2004). Exploring the public understanding of basic genetic concepts. Journal of Genetic Counseling, 13(4), 305-320.
50.
Lerman, C., Biesecker, B., Benkendorf, J. L., Kerner, J., Gomez-Caminero, A., Hughes, C., et al. (1997). Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing. Journal of the National Cancer Institute, 89(2), 148-157.
51.
Lerman, C., Gold, K., Audrain, J., Lin, T. H., Boyd, N. R., Orleans, C. T., et al. (1997). Incorporating biomarkers of exposure and genetic susceptibility into smoking cessation treatment: Effects on smoking-related cognitions, emotions, and behavior change. Health Psychology, 16(1), 87-99.
52.
Lerman, C., Hughes, C., Croyle, R. T., Main, D., Durham, C., Snyder, C., et al. (2000). Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing. Preventive Medicine, 31, 75-80.
53.
Lerman, C., Lustbader, E., Rimer, B., Daly, M., Miller, S., Sands, C., et al. (1995). Effects of individualized breast cancer risk counseling: A randomized trial. Journal of the National Cancer Institute, 87(4), 286-292.
54.
Lerman, C., Narod, S., Schulman, K., Hughes, C., Gomez-Caminero, A., Bonney, G., et al. (1996). BRCA1 testing in families with hereditary breast-ovarian cancer: A prospective study of patient decision making and outcomes. Journal of the American Medical Association, 275(24), 1885-1892.
55.
Lerman, C., Schwartz, M. D., Lin, T. H., Hughes, C., Narod, S., & Lynch, H. T. (1997). The influence of psychological distress on use of genetic testing for cancer risk. Journal of Consulting and Clinical Psychology, 65(3), 414-420.
56.
Lerman, C., Schwartz, M. D., Miller, S. M., Daly, M., Sands, C., & Rimer, B. K. (1996). A randomized trial of breast cancer risk counseling: Interacting effects of counseling, educational level, and coping style. Health Psychology, 15(2), 75-83.
57.
Lipkus, I. M., McBride, C. M., Pollak, K. I., Lyna, P., & Bepler, G. (2004). Interpretation of genetic risk feedback among African American smokers with low socioeconomic status. Health Psychology, 23(2), 178-188.
58.
Loader, S., Levenkron, J. C., & Rowley, P. T. (1998). Genetic testing for breast-ovarian cancer susceptibility: A regional trial. Genetic Testing, 2(4), 305-313.
59.
Loader, S., Shields, C. G., & Rowley, P. T. (2004). Impact of genetic testing for breast-ovarian cancer susceptibility. Genetic Testing, 8(1), 1-12.
60.
Marteau, T., Senior, V., Humphries, S. E., Bobrow, M., Cranston, T., Crook, M. A., et al. (2004). Psychological impact of genetic testing for familial hypercholesterolemia within a previously aware population: A randomized controlled trial. American Journal of Medical Genetics, 128A, 285-293.
61.
Marteau, T. M., & Croyle, R. T. (1998). The new genetics: Psychological responses to genetic testing. BMJ, 316(7132), 693-696.
62.
Marteau, T. M., & Senior, V. (1997). Illness representations after the Human Genome Project: The perceived role of genes in causing illness. In K. J. Petrie & J. A. Weinman (Eds.), Perceptions of health & illness (pp. 241-266). Amsterdam: Harwood.
63.
McBride, C. M., Bepler, G., Lipkus, I. M., Lyna, P., Samsa, G., Albright, J., et al. (2002). Incorporating genetic susceptibility feedback into a smoking cessation program for African-American smokers with low income. Cancer Epidemiology, Biomarkers & Prevention, 11, 521-528.
64.
McCarthy Veach, P., Truesdell, S. E., LeRoy, B. S., & Bartels, D. M. (1999). Client perceptions of the impact of genetic counseling: An exploratory study. Journal of Genetic Counseling, 8(4), 191-216.
65.
McCusker, M. E., Yoon, P. W., Gwinn, M., Malarcher, A. M., Neff, L., & Khoury, M. J. (2004). Family history of heart disease and cardiovascular disease risk-reducing behaviors. Genetics in Medicine, 6(3), 153-158.
66.
McLeroy, K. R., Bibeau, D., Streckler, A., & Glanz, K. (1988). An ecological perspective on health promotion programs. Health Education Quarterly, 15(4), 351-377.
67.
Meijers-Heijboer, E. J., Verhoog, L. C., Brekelmans, C. T. M., Seynaeve, C., Tilanus-Linthorst, M. M. A., Wagner, A., et al. (2000). Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation. Lancet, 355(9220), 2015-2020.
68.
Meiser, B., & Halliday, J. L. (2002). What is the impact of genetic counseling in women at increased risk of developing hereditary breast cancer? A meta-analytic review. Social Science & Medicine, 54, 1463-1470.
69.
Michie, S., French, D. P., & Marteau, T. M. (2002). Predictive genetic testing: Mediators and moderators of anxiety. International Journal of Behavioral Medicine, 9(4), 309-321.
70.
Michigan Department of Community Health. (2004, August). A needs assessment and state plan for Michigan. Genetics through the life cycle: Improving health and preventing disease 2003-08. Lansing, MI: Author.
71.
Offit, K., Groeger, E., Turner, S., Wadsworth, E. A., & Weiser, M. A. (2004). The “duty to warn” a patient’s family members about hereditary disease risks. Journal of the American Medical Association, 292(12), 1469-1473.
72.
Paling, J. (2003). Strategies to help patients understand risk. BMJ, 327, 745-748.
73.
Patenaude, A. F., Schneider, K. A., Kieffer, S. A., Calzone, K. A., Stopfer, J. E., Basili, L. A., et al. (1996). Acceptance of invitations for p53 and BRCA1 predisposition testing: Factors influencing potential utilization of cancer genetic testing. Psycho-Oncology, 5, 241-250.
74.
Peters, N., Rose, A., & Armstrong, K. (2004). The association between race and attitudes about predictive genetic testing. Cancer Epidemiology, Biomarkers & Prevention, 13(3), 361-365.
75.
Peterson, E. A., Milliron, K. J., Lewis, K. E., Goold, S. D., & Merajver, S. D. (2002). Health insurance and discrimination concerns and BRCA1/2 testing in a clinic population. Cancer Epidemiology, Biomarkers & Prevention, 11, 79-87.
76.
Plantinga, L., Natowicz, M. R., Kass, N. E., Hull, S. C., Gostin, L. O., & Faden, R. R. (2003). Disclosure, confidentiality, and families: Experiences and attitudes of those with genetic versus nongenetic medical conditions. American Journal of Medical Genetics Part C, 119C, 51-59.
77.
Roberts, J. S., Barber, M., Brown, T. M., Cupples, L. A., Farrer, L. A., LaRusse, S. A., et al. (2004). Who seeks genetic susceptibility testing for Alzheimer’s disease? Findings from a multisite, randomized clinical trial. Genetics in Medicine, 6(4), 197-203.
78.
Rothman, A. J., & Kiviniemi, M. T. (1999). Treating people with information: An analysis and review of approaches to communicating health risk information. Journal of the National Cancer Institute. Monographs., 25, 44-51.
79.
Schill, A. L. (2000). Genetic information in the workplace. Implications for occupational health surveillance. AAOHN Journal, 48(2), 80-91.
80.
Schwartz, M. D., Lerman, C., Brogan, B., Peshkin, B. N., Halbert, C. H., DeMarco, T., et al. (2004). Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients. Journal of Clinical Oncology, 22(10), 1823-1829.
81.
Schwartz, M. D., Peshkin, B. N., Hughes, C., Main, D., Isaacs, C., & Lerman, C. (2002). Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample. Journal of Clinical Oncology, 20(2), 514-520.
82.
Senior, V., Marteau, T. M., & Peters, T. J. (1999). Will genetic testing for predisposition for disease result in fatalism? A qualitative study of parents responses to neonatal screening for familial hypercholesterolaemia. Social Science and Medicine, 48, 1857-1860.
83.
Shiloh, S., & Sagi, M. (1989). Effect of framing on the perception of genetic recurrence risks. American Journal of Medical Genetics, 33, 130-135.
84.
Singer, E., Antonucci, T., & Van Hoewyk, J. (2004). Racial and ethnic variations in knowledge and attitudes about genetic testing. Genetic Testing, 8(1), 31-43.
85.
Sorenson, J. R., & Cheuvront, B. (1993). The Human Genome Project and health behavior and health education research. Health Education Research, 8(4), 589-593.
86.
Sorenson, J. R., Cheuvront, B., DeVellis, B., Callanan, N., Silverman, L., Koch, G., et al. (1997). Acceptance of home and clinic-based cystic fibrosis carrier education and testing by first, second, and third degree relatives of CF patients. American Journal of Medical Genetics, 70, 121-129.
87.
Sorenson, J. R., Lakon, C., Spinney, T., & Jennings-Grant, T. (2004). Assessment of a decision aid to assist genetic testing research participants in the informed consent process. Genetic Testing, 8(3), 336-346.
88.
Stokols, D. (1992). Establishing and maintaining health environments: Toward a social ecology of health promotion. American Psychologist, 47(1), 6-22.
89.
Stokols, D. (1996). Translating social ecological theory into guidelines for community health promotion. American Journal of Health Promotion, 10(4), 282-298.
90.
Theisen, V., Duquette, D., Kardia, S., Wang, C., Beene-Harris, R., & Bach, J. (2005). Blood Pressure Sunday: Introducing genomics to the community through family history. Preventing Chronic Disease [serial online], 2(2). Available from http://www.cdc.gov/pcd/issues/2005/apr/04_0134.htm
91.
Unic, I., Verhoef, L. C. G., Stalmeier, P. F. M., & Van Daal, W. A. J. (2000). Prophylactic mastectomy or screening in women suspected to have the BRCA1/2 mutation: A prospective pilot study of women’s treatment choices and medical and decision-analytic recommendations. Medical Decision Making, 20, 251-262.
92.
van Roosmalen, M. S., Stalmeier, P. F. M., Verhoef, L. C. G., Hoekstra-Weebers, J. E. H. M., Oosterwijk, J. C., Hoogerbrugge, N., et al. (2004). Impact of BRCA1/2 testing and disclosure of a positive test result on women affected and unaffected with breast or ovarian cancer. American Journal of Medical Genetics Part A, 124A, 346-355.
93.
Walter, F. M., Emery, J., Braithwaite, D., & Marteau, T. M. (2004). Lay understanding of familial risk of common chronic diseases: A systematic review and synthesis of qualitative research. Annals of Family Medicine, 2(6), 583-594.
94.
Wang, C., Gonzalez, R., & Merajver, S. D. (2004). Assessment of genetic testing and related counseling services: Current research and future directions. Social Science and Medicine, 58, 1427-1442.
95.
Watson, M., Duvivier, V., Wade Walsh, M., Ashley, S., Davidson, J., Papaikonomou, M., et al. (1998). Family history of breast cancer: What do women understand and recall about their genetic risk?Journal of Medical Genetics, 35, 731-738.
96.
Westman, J., Hampel, H., & Bradley, T. (2000). Efficacy of a touchscreen computer based family cancer history questionnaire and subsequent cancer risk assessment. Journal of Medical Genetics, 37, 354-360.
97.
Wideroff, L., Freedman, A. N., Olson, L., Klabunde, C. N., Davis, W., Srinath, K. P., et al. (2003). Physician use of genetic testing for cancer susceptibility: Results of a national survey. Cancer Epidemiology, Biomarkers & Prevention, 12, 295-303.
98.
Wiggins, S., Whyte, P., Huggins, M., Adam, S., Theilmann, J., Bloch, M., et al. (1992). The psychological consequences of predictive testing for Huntington’s disease. New England Journal of Medicine, 327, 1401-1405.
99.
Woloshin, S., Schwartz, L. M., Black, W. C., & Welch, G. (1999). Women’s perceptions of breast cancer risk: How you ask matters. Medical Decision Making, 19, 221-229.
100.
Yoon, P., & Scheuner, M. (2004). The family history public health initiative. In M. Gwinn, S. Bedrosian, D. Ottman, & M. J. Khoury (Eds.), Genomics and population health: United States 2003 (pp. 39-45). Atlanta, GA: Centers for Disease Control and Prevention, Office of Genomics and Disease Prevention.
101.
Yoon, P. W., Scheuner, M. T., & Khoury, M. J. (2003). Research priorities for evaluating family history in the prevention of chronic diseases. American Journal of Preventive Medicine, 24(2), 128-135.
102.
Yoon, P. W., Scheuner, M. T., Peterson-Oehike, K., Gwinn, M., Faucett, A., & Khoury, M. J. (2002). Can family history be used as a tool for public health and preventive medicine?Genetics in Medicine, 4(4), 304-310.
